Stockscreener 앱 받기
0.2314
6.32%
-0.0156
시간 외 거래:
.23
-0.0014
-0.61%
전일 마감가:
$0.247
열려 있는:
$0.2367
하루 거래량:
8.21M
Relative Volume:
1.37
시가총액:
$12.10M
수익:
$9.00M
순이익/손실:
$-7.21M
주가수익비율:
-0.4207
EPS:
-0.55
순현금흐름:
$-7.59M
1주 성능:
+28.56%
1개월 성능:
+18.00%
6개월 성능:
-40.67%
1년 성능:
-98.16%
1일 변동 폭
$0.215
$0.2445
1주일 범위
$0.175
$0.2544
52주 변동 폭
$0.1204
$14.40
Applied Dna Sciences Inc Stock (APDN) Company Profile
명칭
Applied Dna Sciences Inc
전화
631-240-8800
주소
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
APDN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
0.2314 | 12.10M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-02-12 | 개시 | ROTH Capital | Buy |
| 2021-01-14 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-20 | 재확인 | H.C. Wainwright | Buy |
| 2020-07-02 | 개시 | H.C. Wainwright | Buy |
| 2016-11-14 | 재확인 | Maxim Group | Buy |
| 2016-05-13 | 재확인 | Maxim Group | Buy |
| 2015-10-08 | 재확인 | Maxim Group | Buy |
| 2015-05-26 | 개시 | The Benchmark Company | Speculative Buy |
| 2015-02-10 | 재확인 | Maxim Group | Buy |
| 2015-01-13 | 개시 | Maxim Group | Buy |
모두보기
Applied Dna Sciences Inc 주식(APDN)의 최신 뉴스
SABBY MANAGEMENT, LLC Acquires Significant Stake in Applied DNA Sciences Inc - GuruFocus.com
Featured Company NewsApplied DNA Sciences Enters into CertainT Trademark License Agreement with Techmer PM - AccessWire
When Would Be The Best Time To Buy Applied Dna Sciences Inc (NASDAQ: APDN) Stock? - Stocks Register
Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA - AccessWire
Applied DNA Sciences Secures Landmark Approval for Revolutionary CAR T-Cell Therapy Trial in Czech Republic - StockTitan
Why US Futures Are Rising WednesdayCorvus Pharma (NASDAQ:CRVS), Applied DNA Sciences (NASDAQ:APDN) - Benzinga
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Benzinga
General Mills, Micron Technology And 3 Stocks To Watch Heading Into Wednesday - Benzinga
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot - CT Insider
Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Applied DNA Sciences Inc. (APDN) reports earnings - Quartz
Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines - AccessWire
Applied DNA Sciences Pivots to Genetic Medicine Manufacturing, Plans Major Restructuring Amid Revenue Drop - StockTitan
Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out - AccessWire
Applied DNA Sciences Sets Q4 Earnings Date, to Update on Key Manufacturing Expansion - StockTitan
APDN stock plunges to 52-week low of $0.14 amid steep decline - Investing.com Australia
APDN stock plunges to 52-week low of $0.15 amid market challenges - Investing.com
Applied DNA Sciences, Inc. (NASDAQ:APDN) Sees Large Decrease in Short Interest - Defense World
Analysts Predict How High Applied Dna Sciences Inc (APDN) Will Go. - Stocks Register
Applied DNA stock jumps amid U.S. government mpox update - MSN
Anson Funds Management LP Acquires New Stake in Applied DNA Scie - GuruFocus.com
APDN stock plunges to 52-week low, touches $0.17 - Investing.com India
APDN stock plunges to 52-week low, touches $0.17 By Investing.com - Investing.com UK
Short Interest in Applied DNA Sciences, Inc. (NASDAQ:APDN) Declines By 28.4% - Defense World
Applied DNA faces Nasdaq delisting over share price By Investing.com - Investing.com UK
Applied DNA faces Nasdaq delisting over share price - Investing.com
Applied DNA Sciences Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - Defense World
APDN stock plunges to 52-week low, touches $0.19 By Investing.com - Investing.com Australia
Applied DNA stock slides after pricing $6.5M securities offering - MSN
APDN stock plunges to 52-week low, touches $0.19 - Investing.com India
Applied DNA announces $6.5 million securities offering By Investing.com - Investing.com Canada
Applied DNA announces $6.5 million securities offering - Investing.com India
APDN Stock Earnings: Applied DNA Sciences Reported Results for Q3 2024 - MSN
Crude Oil Gains Over 2%; Eli Lilly Cuts 2024 Forecast - Benzinga
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement - AccessWire
Applied DNA Sciences, Inc. announced that it expects to receive $6.5 million in funding - Marketscreener.com
It makes sense and dollars to buy Applied Dna Sciences Inc (APDN) stock - SETE News
Navigating APDN Stock: Applied Dna Sciences Inc Journey - The InvestChronicle
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16 - AccessWire
Did Applied Dna Sciences Inc (APDN) perform well in the last session? - US Post News
In the Green: Applied Dna Sciences Inc (APDN) Closes at 0.31, Up/Down -1.87 from Previous Day - The Dwinnex
Applied Dna Sciences Inc [APDN] is -97.40% lower this YTD. Is it still time to buy? - The DBT News
Choosing between riding the trend or protecting profits: Applied Dna Sciences Inc (APDN) - US Post News
Applied Dna Sciences Inc (APDN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
자본화:
|
볼륨(24시간):